trial
as of 2026-07-01Positron Emission Tomagraphy (PET) Study Following a Single Oral Dose of OPC-34712
NCTId NCT00805454
at a glance
Phase 1 · Completed
Enrollment 15 (actual)
Primary completion 2009-07
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 1
Status
Completed
Enrollment
15 (actual)
Study type
Interventional
Allocation
—
Model
—
Masking
None
Start
2008-12
Primary completion
2009-07
Eligibility
ALL · 18 Years · 45 Years
Interventions & indications
Indications
Sponsors
Investigators
2
Dean Wong, MD,PhDPrincipal Investigator
Stephen Bart, MDPrincipal Investigator
Sites
0 total
Facts & assertions
4 sourced
Enrollment
15
Phase
PHASE1
Primary Completion Date
2009-07
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
collaborator
indication
indication
indication
investigator
person
person